Protect your runway before hidden cost exposure quietly compresses it.
Growth-stage biotech and medtech companies rarely fail because of weak science.
They struggle when burn rate visibility becomes distorted across disconnected lifecycle decisions — CMO contracts, regulatory timing, portfolio prioritisation, and cross-functional misalignment.
What looks manageable on a dashboard can quietly compound into runway compression.
The Runway Risk & Cost Exposure Audit™ stress-tests whether your 12–24 month capital assumptions fully reflect lifecycle cost exposure.
Identify where your organisation may be quietly losing €250k–€10m per year — before it impacts runway, valuation, or deal terms.
Unseen cost leakage can accumulate in any one of the following ways:
- R&D programs that should have been stopped earlier
- CMC and manufacturing decisions that inflate COGS long-term
- Regulatory rework caused by late or fragmented strategy
- Commercial blind spots that destroy value at launch
- Consultant and external spend with unclear ROI
These costs accumulate silently — often until investors, partners, or acquirers expose them.
Runway Risk & Cost Exposure Audit™
The Runway Risk & Cost Exposure Audit™ is a structured, executive-level diagnostic designed for:
- Biotech and medtech SMEs
- CDMOs and platform technology companies
- University spin-outs and scale-ups
It helps you identify, quantify, and prioritise hidden cost risks across your entire value chain — in under 60 minutes.
This is not a financial audit.
It is a strategic cost–value diagnostic.
What the Audit Covers
The Audit Covers 6 Cost Exposure Domains
• R&D Strategy & Portfolio Focus
• CMC, Manufacturing & Supply Chain
• Regulatory & Quality Strategy
• Commercial Readiness & Market Access
• Organisational Design & External Spend
• Data, Digital & Decision Infrastructure
Each domain identifies where lifecycle misalignment may inflate burn rate.
What You Receive – Runway Risk & Cost Exposure Audit™
Designed for CEOs, CFOs and COOs of growth-stage life science SMEs who need sharper capital visibility.
✔ 30-question executive diagnostic
✔ Scoring framework with cost exposure ranges (€)
✔ 6 cross-functional lifecycle domains
✔ Indicative exposure mapping (€250k–€10m+)
✔ Completion time: 45–60 minutes
This is not a financial audit.
It is a runway visibility diagnostic.
After completing this audit, you will have:
• A clearer view of your 12–24 month exposure profile
• A prioritised map of high-risk domains
• Sharper insight ahead of board or investor conversations
What Your Score Really Means
Score Range | Risk Level | Indicative Annual Cost Exposure |
0–40 | Severe | €2m – €10m+ |
41–70 | High | €1m – €5m |
71–95 | Moderate | €250k – €1m |
96–120 | Low | < €250k |
Most leadership teams underestimate how quickly cross-functional exposure compounds.
Who This Is For
• CEOs, Founders, COOs
• CFOs and Heads of Finance
• Strategy and Portfolio Leaders
Particularly valuable for organisations:
– Preparing for scale-up or financing
– Managing multiple assets
– Approaching partnering, licensing or M&A
Who This Audit Is Not For
- Companies seeking tactical fixes or templates
- Organisations outsourcing thinking
- Teams unwilling to act on uncomfortable insights
This audit surfaces where value is leaking — not how to cosmetically mask it.
How this Audit is Used
The Runway Risk & Cost Exposure Audit™ is a self-guided diagnostic designed to help leaders surface potential areas of hidden cost and value erosion.
Executive Runway Risk Review™
Many organisations choose to review their audit results in a confidential 90-minute executive session to:
• Quantify burn rate exposure
• Stress-test capital assumptions
• Prioritise high-impact corrective action
• Protect valuation narrative
This session translates audit insight into a 12–24 month runway perspective.
For organisations seeking deeper clarity, the audit often becomes the starting point for a confidential Executive Runway Risk Review™.
To set up this Executive Runway Risk Review™ meeting, click here to complete the confidential contact form.
Not Ready for the Full Diagnostic?
Download the Executive Brief for an overview of common runway risk patterns.
Download the Executive Brief by filling out the form below to understand:
• Where cost leakage typically hides
• Why it’s rarely visible in standard reporting
• How executives surface it early
About i3 Consult
Founded in 2002, i3 Consult works with life science organisations to identify and correct structural cost–value misalignment across the product lifecycle.